首页|期刊导航|生物骨科材料与临床研究|不同浓度BMAC对兔体外距骨软骨损伤细胞中IL-1、TNF-α、IL-6及MMP-13、Col2a1表达影响的实验研究

不同浓度BMAC对兔体外距骨软骨损伤细胞中IL-1、TNF-α、IL-6及MMP-13、Col2a1表达影响的实验研究OA

Experimental study on the effects of different concentrations of BMAC on the expression of IL-1,TNF-α,IL-6,MMP-13,and Col2a1 in rabbit osteochondral injury cells in vitro

中文摘要英文摘要

目的 探讨不同浓度骨髓浓缩抽吸物(bone marrow aspirate concentrate,BMAC)对兔距骨软骨细胞损伤后炎症因子及软骨基质代谢的调控作用,为优化BMAC治疗距骨软骨损伤的浓度选择提供实验依据.方法 体外分离新西兰大白兔距骨关节软骨细胞,随机分为对照组、炎症诱导组、低浓度BMAC组、中浓度BMAC组及高浓度BMAC组,除对照组外,其余各组均采用10 ng/mL的IL-1β处理软骨细胞24 h构建距骨软骨损伤细胞,其中低、中、高浓度BMAC组分别加入10、20、50 μL/mL的BMAC进行干预,通过HE染色评估各组细胞基质生长情况,并通过酶联免疫吸附剂测定法(enzyme-linked immunosorbent assay,ELISA)检测上清液IL-1、TNF-α、IL-6的含量和实时荧光定量PCR(reverse transcription-polymerase chain reaction,RT-qPCR)分析软骨细胞中基质金属蛋白酶-13(MMP-13)及Ⅱ型胶原α1链基因(Col2a1)的mRNA表达水平,蛋白免疫印迹法检测软骨细胞中MMP-13、Col2a1蛋白表达水平.结果 与对照组相比,炎症诱导组上清液中IL-1、TNF-α、IL-6含量均升高,且IL-1升高极明显(P<0.001),TNF-α升高明显(P<0.05),MMP-13的mRNA及蛋白水平表达升高(P<0.001),Col2a1的mRNA及蛋白水平表达降低(P<0.01);与炎症诱导组比较,20 ng/mL BMAC干预组的软骨细胞更接近正常软骨细胞形态.与炎症诱导组比较,低、中、高浓度BMAC组上清液中IL-1、TNF-α、IL-6含量均降低,且各炎症因子降低随BMAC浓度增加呈下降趋势;MMP-13的mRNA及蛋白水平表达均降低,Col2a1的 mRNA 及蛋白水平表达均升高;其中,高浓度 BMAC 显著下调 MMP-13 的 mRNA 及蛋白水平表达(P<0.001),并上调Col2a1的mRNA及蛋白水平表达(P<0.001).结论 BMAC可以抑制距骨软骨损伤细胞中的炎症因子的表达,下调MMP-13及促进Col2a1表达水平,具有浓度依赖性,50 μL/mL BMAC可能为最佳浓度.

Objective To investigate the regulatory effects of different concentrations of bone marrow concentrate aspiration(BMAC)on inflammatory factors and cartilage matrix metabolism after injury of rabbit talus chondrocytes,and to provide experimental evidence for optimizing the concentration selection of BMAC in the treatment of talus cartilage injury.Methods New Zealand white rabbit talus joint chondrocytes were isolated in vitro and randomly divided into a control group,an inflammation induction group,a low concentration BMAC group,a medium concentration BMAC group,and a high concentration BMAC group.Except for the control group,all other groups were treated with 10 ng/mL IL-1 β for 24 hours to construct talus soft bone injury cells.The low,medium,and high concentration BMAC groups were intervened with 10,20 and 50 μL/mL BMAC,respectively.Cell morphology was evaluated by cell morphology observation,and the contents of IL-1,TNF-α,and IL-6 in the supernatant were detected by enzyme-linked immunosorbent assay(ELISA)and real-time fluorescence quantitative PCR(Reverse TransPCR).Analysis of mRNA expression of matrix metalloproteinase-13(MMP-13)and type Ⅱ collagen alpha 1 chain gene(Col2a1)in chondrocytes using script polymerase chain reaction RT qPCR.The expression levels of MMP-13 and Col2a1 proteins in chondrocytes were detected by protein immunoblotting.Results Compared with the control group,the levels of IL-1,TNF-α,and IL-6 in the supernatant of the inflammation induced group were all increased,and IL-1 increased significantly(P<0.001),TNF-α increased significantly(P<0.05),MMP-13 mRNA and protein expression increased(P<0.001),and Col2a1 mRNA and protein expression decreased(P<0.01).Compared with the inflammation induced group,the chondrocytes in the medium concentration BMAC intervention group were closer to normal chondrocyte morphology.Compared with the the inflammation induced group the levels of IL-1,TNF-α,and IL-6 in the supernatant of low,medium,and high concentration BMAC groups were all reduced,and the decrease in various inflammatory factors showed a decreasing trend with increasing BMAC concentration.The mRNA and protein levels of MMP-13 decreased,while the mRNA and protein levels of Col2a1 increased.Among them,high concentrations of BMAC significantly downregulated the expression of MMP-13 mRNA and protein levels(P<0.001),and upregulated the expression of Col2a1 mRNA and protein levels(P<0.001).Conclusion Compared with other concentrations of BMAC group,20 μL/mL BMAC can better improve the cell morphology induced by inflammation;50 μL/mL BMAC can effectively inhibit IL-1,TNF-α,IL-6,as well as inhibit matrix degradation and promote type Ⅱ collagen regeneration in talus cartilage injury.

任华;孟子涵;刘君;史雪峰;李鑫;解晓融;张超;胡鸿鹏;杜虎羽

山西医科大学第九临床医学院,山西 太原,030032山西医科大学第九临床医学院,山西 太原,030032北京大学第一医院太原医院骨科 山西 太原,030032北京大学第一医院太原医院骨科 山西 太原,030032长治医学院附属第一临床医学院,山西 长治,046000山西医科大学第九临床医学院,山西 太原,030032北京大学第一医院太原医院骨科 山西 太原,030032北京大学第一医院太原医院骨科 山西 太原,030032北京大学第一医院太原医院骨科 山西 太原,030032

医药卫生

骨髓浓缩抽吸物距骨软骨损伤炎症因子软骨修复

Bone marrow aspirate concentrateosteochondral lesion of talusInflammatory factorsCartilage repair

《生物骨科材料与临床研究》 2026 (3)

16-21,6

太原市区域医疗中心科技创新计划项目(202220)2024年度太原市"六个一批"专项行动重点项目(Z2024002)

10.3969/j.issn.1672-5972.2026.03.003

评论